INOVIO Form 4 — KIES PETER (Feb. 26, 2022)

Summary

Peter Kies, CFO of INOVIO PHARMACEUTICALS, INC. [ INO ], reports 22,545 Restricted Stock Units vesting on 02/26/2022 from a 67,633-unit award, with 12,555 shares withheld by the issuer at $ 3.22 for tax obligations. Grants dated the same day comprise a Common Stock Option for 192,800 shares at $ 3.22, expiring 02/26/2032, of which 48,200 shares vested on February 26, 2022, and 143,900 Restricted Stock Units due to vest 47,967 shares on February 26, 2023, 47,967 on February 26, 2024 and 47,966 on February 26, 2025. Direct holdings end at 140,778 shares, with 4,500 listed by spouse. The form is signed Peter Kies, 03/01/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * KIES PETER (Last) (First) (Middle) C/O INOVIO PHARMACEUTICALS, INC. 6769 MESA RIDGE ROAD (Street) SAN DIEGO CA 92121 (City) (State) (Zip) | KIES PETER | (Last) | (First) | (Middle) | C/O INOVIO PHARMACEUTICALS, INC. | 6769 MESA RIDGE ROAD | SAN DIEGO | CA | 92121 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol INOVIO PHARMACEUTICALS, INC. [ INO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CFO | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | CFO
3. Date of Earliest Transaction
 (Month/Day/Year) 02/26/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 02/26/2022 | M | 22,545 | A | (1) | 153,333 | D
Common Stock | 02/26/2022 | F (2) | 12,555 | D | $ 3.22 | 140,778 | D
Common Stock | 4,500 | I | By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Restricted Stock Unit | (1) | 02/26/2022 | M | 22,545 | (1) | (1) | Common Stock | 22,545 | $ 0 (1) | 45,088 | D
Common Stock Option | $ 3.22 | 02/26/2022 | A | 192,800 | 02/26/2022 (3) | 02/26/2032 | Common Stock | 192,800 | $ 0 | 192,800 | D
Restricted Stock Unit | (4) | 02/26/2022 | A | 143,900 | (4) | (4) | Common Stock | 143,900 | $ 0 (4) | 143,900 | D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
3. The vesting schedule for the 192,800 options is as follows: 48,200 shares vested on February 26, 2022; 48,200 shares will vest on February 26, 2023; 48,200 shares will vest on February 26, 2024; 48,200 shares will vest on February 26, 2025.
4. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 143,900 restricted stock units is as follows: 47,967 shares will vest on February 26, 2023; 47,967 shares will vest on February 26, 2024; 47,966 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Remarks:
Peter Kies | 03/01/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_INO_4_filed2022-03-01_0001055726-22-000012.xml

Size

20,677 bytes

SHA-256

c5177946fb8477d40dace6d4beb77291067c3bfdb82dc11cc61cbd1b6f3e6ab2

Our copy

SEC_INO_4_filed2022-03-01_0001055726-22-000012.xml

Original

www.sec.gov